BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15312176)

  • 21. A novel serotonin transporter ligand: (5-iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol.
    Zhuang Z; Choi S; Hou C; Mu M; Kung M; Acton PD; Kung HF
    Nucl Med Biol; 2000 Feb; 27(2):169-75. PubMed ID: 10773546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography.
    Wilson AA; Ginovart N; Hussey D; Meyer J; Houle S
    Nucl Med Biol; 2002 Jul; 29(5):509-15. PubMed ID: 12088720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [11C]5-bromo-2-[2-(dimethylaminomethylphenylsulfanyl)]phenylamine ([11C]DAPA).
    Huang Y; Hwang DR; Zhu Z; Bae SA; Guo N; Sudo Y; Kegeles LS; Laruelle M
    Nucl Med Biol; 2002 Oct; 29(7):741-51. PubMed ID: 12381454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
    de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
    Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroimaging of the serotonin reuptake site requires high-affinity ligands.
    Elfving B; Madsen J; Knudsen GM
    Synapse; 2007 Nov; 61(11):882-8. PubMed ID: 17657807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
    Owens MJ; Knight DL; Nemeroff CB
    Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S-[18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats.
    Marjamäki P; Zessin J; Eskola O; Grönroos T; Haaparanta M; Bergman J; Lehikoinen P; Forsback S; Brust P; Steinbach J; Solin O
    Synapse; 2003 Jan; 47(1):45-53. PubMed ID: 12422372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
    J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA).
    Huang Y; Narendran R; Bae SA; Erritzoe D; Guo N; Zhu Z; Hwang DR; Laruelle M
    Nucl Med Biol; 2004 Aug; 31(6):727-38. PubMed ID: 15246363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates?
    Goulet M; Miller GM; Bendor J; Liu S; Meltzer PC; Madras BK
    Synapse; 2001 Dec; 42(3):129-40. PubMed ID: 11746710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of FlipIDAM as a SERT-selective SPECT imaging agent.
    Lemoine L; Lieberman BP; Ploessl K; Zheng P; Kung HF
    Nucl Med Biol; 2013 Oct; 40(7):879-86. PubMed ID: 23856117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
    Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
    J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter.
    Helfenbein J; Sandell J; Halldin C; Chalon S; Emond P; Okubo Y; Chou YH; Frangin Y; Douziech L; Gareau L; Swahn CG; Besnard JC; Farde L; Guilloteau D
    Nucl Med Biol; 1999 Jul; 26(5):491-9. PubMed ID: 10473187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
    Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
    J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional coupling of serotonin and noradrenaline transporters.
    Horschitz S; Hummerich R; Schloss P
    J Neurochem; 2003 Aug; 86(4):958-65. PubMed ID: 12887693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET.
    Lu JQ; Ichise M; Liow JS; Ghose S; Vines D; Innis RB
    J Nucl Med; 2004 Sep; 45(9):1555-9. PubMed ID: 15347724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas.
    Lanzenberger R; Kranz GS; Haeusler D; Akimova E; Savli M; Hahn A; Mitterhauser M; Spindelegger C; Philippe C; Fink M; Wadsak W; Karanikas G; Kasper S
    Neuroimage; 2012 Nov; 63(2):874-81. PubMed ID: 22828162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand.
    Oya S; Choi SR; Hou C; Mu M; Kung MP; Acton PD; Siciliano M; Kung HF
    Nucl Med Biol; 2000 Apr; 27(3):249-54. PubMed ID: 10832081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1342-53. PubMed ID: 11702049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.